Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DARBEPOETIN ALFA Cause Product use issue? 12 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Product use issue have been filed in association with DARBEPOETIN ALFA (ARANESP). This represents 0.0% of all adverse event reports for DARBEPOETIN ALFA.

12
Reports of Product use issue with DARBEPOETIN ALFA
0.0%
of all DARBEPOETIN ALFA reports
1
Deaths
8
Hospitalizations

How Dangerous Is Product use issue From DARBEPOETIN ALFA?

Of the 12 reports, 1 (8.3%) resulted in death, 8 (66.7%) required hospitalization, and 2 (16.7%) were considered life-threatening.

Is Product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DARBEPOETIN ALFA. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does DARBEPOETIN ALFA Cause?

Death (12,264) Hospitalisation (5,682) Product storage error (1,619) Off label use (1,586) Circumstance or information capable of leading to medication error (1,050) Haemodialysis (907) Pneumonia (733) Fall (726) Anaemia (562) Dialysis (555)

What Other Drugs Cause Product use issue?

INFLIXIMAB (12,752) DUPILUMAB (10,575) POLYETHYLENE GLYCOL 3350 (9,432) METHOTREXATE (8,185) DICLOFENAC (8,009) RITUXIMAB (6,948) ADALIMUMAB (6,379) ETANERCEPT (6,062) TOCILIZUMAB (5,944) ABATACEPT (5,915)

Which DARBEPOETIN ALFA Alternatives Have Lower Product use issue Risk?

DARBEPOETIN ALFA vs DARIDOREXANT DARBEPOETIN ALFA vs DARIFENACIN HYDROBROMIDE DARBEPOETIN ALFA vs DAROLUTAMIDE DARBEPOETIN ALFA vs DARUNAVIR DARBEPOETIN ALFA vs DARUNAVIR ETHANOLATE

Related Pages

DARBEPOETIN ALFA Full Profile All Product use issue Reports All Drugs Causing Product use issue DARBEPOETIN ALFA Demographics